| DB ID | MyCo_4512 |
| Title | Vaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: A non-targeted LC-MS pilot study |
| Year | 2018 |
| PMID | 30133508 |
| Fungal Diseases involved | Vulvovaginal candidiasis |
| Associated Medical Condition | None |
| Genus | Candida |
| Species | spp. |
| Organism | Candida spp. |
| Ethical Statement | The study was approved by the Ethics and Research Committee at the Uni- versity of Campinas, CAAE n˚ 60648016.8.0000.5404, and written informed consent was obtained from all participants. |
| Site of Infection | Vagina |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Vaginal Fluid |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | 1-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphate |
| Biomarker Full Name | 1-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphate |
| Biomarker Type | Negative |
| Biomolecule | Lipid |
| Geographical Location | Brazil |
| Cohort | Twenty-four women were included in this study: eight with vulvovaginal candidiasis, eight with cytolytic vaginosis and eight with no vaginal infections or dysbiosis (control group). |
| Cohort No. | 24 Patients and 8 control |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Liquid chromatography |
| Analysis Method | LC-MS pilot study |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | LC-MS pilot study |
| Up Regulation Down Regulation | Negative |
| Sequence Data | None |
| External Link | None |
